Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 90
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 13(1): 21713, 2023 12 07.
Artigo em Inglês | MEDLINE | ID: mdl-38065952

RESUMO

Despite the extensive literature on the retrieval of digestible starches from archaeological contexts, there are still significant concerns regarding their genuine origin and durability. Here, we propose a multi-analytical strategy to identify the authenticity of ancient starches retrieved from macrolithic tools excavated at Upper Paleolithic sites in the Pontic steppe. This strategy integrates the morphological discrimination of starches through optical microscopy and scanning electron microscopy with single starch chemo-profiling using Fourier transform infrared imaging and microscopy. We obtained evidence of aging and biomineralization in the use-related starches from Palaeolithic sites, providing a methodology to establish their ancient origin, assess their preservation status, and attempt their identification. The pivotal application of this multidisciplinar approach demonstrates that the macrolithic tools, from which starches were dislodged, were used for food-processing across the Pontic Steppe around 40,000 years ago during the earliest colonization of Eurasia by Homo sapiens.


Assuntos
Arqueologia , Amido , Humanos , Amido/química
3.
Eksp Klin Farmakol ; 55(3): 52-4, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1458166

RESUMO

It has been established in experiments on white rats that prolonged (for 2 weeks) intoxication with antituberculous drugs (isoniazid plus rifampicin plus pyrazinamide) results in cytolytic liver injury. This manifests by hyperaminotransferasemia, initiation of lipid peroxidation, suppression of the antioxidant system and bile production. Daily injections of tocopherol acetate (15 mg/kg) and riboxine (100 mg/kg) together with administration of antituberculous drugs reduce their hepatotoxicity. The combined use of these hepatoprotectors and antioxidants provides a dramatic increase of their efficacy in durable intoxication with antituberculous drugs.


Assuntos
Antituberculosos/toxicidade , Inosina Difosfato/uso terapêutico , Fígado/efeitos dos fármacos , Vitamina E/análogos & derivados , alfa-Tocoferol/análogos & derivados , Animais , Antituberculosos/intoxicação , Doença Crônica , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Masculino , Intoxicação/tratamento farmacológico , Ratos , Tocoferóis , Vitamina E/uso terapêutico
4.
Eksp Klin Farmakol ; 55(2): 45-7, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1422454

RESUMO

It has been established in experiments on white rats that antituberculous drugs (isoniazid, rifampicin, ethambutol) given in toxic doses affect the liver, its membranes and organelles, inhibit bile production and bioenergy. This is supported by activation of aspartate and alanine aminotransferases, (ALT and AST), alkaline phosphatase in blood serum and acid phosphatase in the liver, by a decrease of the activity of Na(+)-, K(+)-ATPase, succinate dehydrogenase and cytochromoxidase in the liver, lowering of the rate of bile secretion, excretion of bile acids, bilirubin and cholesterol with bile. Provided the drugs are administered in combination, the hepatotoxicity rises, particularly in combination of isoniazid with rifampicin, and especially as isoniazid is combined with rifampicin and ethambutol.


Assuntos
Etambutol/toxicidade , Isoniazida/toxicidade , Fígado/efeitos dos fármacos , Rifampina/toxicidade , Animais , Bile/efeitos dos fármacos , Bile/metabolismo , Interações Medicamentosas , Fígado/enzimologia , Masculino , Ratos
5.
Eksp Klin Farmakol ; 55(1): 61-3, 1992.
Artigo em Russo | MEDLINE | ID: mdl-1305440

RESUMO

It has been shown in experiments on white rats that chronic (for one month) intoxication with CCl4 and C2H5OH results in liver injury. It manifests by activation of aminotransferases (ALT, AST) and alkaline phosphatase in blood serum, initiation of lipid peroxidation, depletion of the liver pool of reduced glutathione, and suppression of bile production. The liver preparations (sirepar and vitohepat) reduce hepatotoxicity of the poisons in question. The use of vitohepat and sirepar in combination with carsil potentiated hepatoprotective and antioxidative activity of the liver preparations.


Assuntos
Antioxidantes/uso terapêutico , Intoxicação por Tetracloreto de Carbono/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Hepatite Alcoólica/tratamento farmacológico , Extratos Hepáticos/uso terapêutico , Silimarina/uso terapêutico , Animais , Intoxicação por Tetracloreto de Carbono/sangue , Doença Hepática Induzida por Substâncias e Drogas/sangue , Doença Crônica , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Hepatite Alcoólica/sangue , Masculino , Ratos
7.
Probl Tuberk ; (3): 57-9, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1871097

RESUMO

Two-week administration of isoniazid, rifampicin (50 mg/kg and pyrazinamide (1,5 g/kg) to white rats brings about liver affection characterized by a higher activity of alanine and aspartate aminotransferases, lipid peroxidation activation and bile production inhibition. With the liver affected by antituberculous drugs, protective action is provided by acetate tocopherol an antioxidant, and piracetam riboxin and pyriditol, antihypoxic agents.


Assuntos
Antioxidantes/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Modelos Animais de Doenças , Hepatite Animal/tratamento farmacológico , Inosina Difosfato/uso terapêutico , Isoniazida/efeitos adversos , Piracetam/uso terapêutico , Pirazinamida/efeitos adversos , Rifampina/efeitos adversos , Vitamina E/uso terapêutico , Animais , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Hepatite Animal/etiologia , Isoniazida/antagonistas & inibidores , Masculino , Pirazinamida/antagonistas & inibidores , Ratos , Rifampina/antagonistas & inibidores
9.
Probl Tuberk ; (10): 77-9, 1991.
Artigo em Russo | MEDLINE | ID: mdl-1788241

RESUMO

Isoniazid, rifampicin and ethambutol administered in equimolecular dosages (50, 250 and 100 mg/kg, respectively) for 4 days caused liver affection. This was manifested by elevated activity of serum aminotransferases and alkaline phosphatase, inhibition of lipid peroxidation of hepatocyte membranes and antioxidative system dysfunctions. Isoniazid and rifampicin were proved to be most hepatotoxic. The combined use of antituberculous drugs increases their membrane-damaging action, especially when isoniazid and rifampicin are used together, but mostly when isoniazid in combination with rifampicin and ethambutol is applied.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/etiologia , Modelos Animais de Doenças , Etambutol/toxicidade , Isoniazida/toxicidade , Fígado/efeitos dos fármacos , Rifampina/toxicidade , Animais , Doença Hepática Induzida por Substâncias e Drogas/fisiopatologia , Relação Dose-Resposta a Droga , Etambutol/administração & dosagem , Isoniazida/administração & dosagem , Fígado/fisiopatologia , Testes de Função Hepática , Masculino , Ratos , Rifampina/administração & dosagem
10.
Farmakol Toksikol ; 53(6): 52-4, 1990.
Artigo em Russo | MEDLINE | ID: mdl-2081569

RESUMO

In experiments on albino rats it was established that three administrations of indomethacin in a dose of 0.01 g/kg body weight induced a severe damage of the liver characterized by disturbances of hepatocytic membranes, bile-producing and protein-producing functions of the liver, an enhancement of lipid peroxidation, a decrease of reduced glutathione pool. Antioxidants (tocopherol acetate, essentiale, legalon, flacumin) limit manifestations of indomethacin, hepatotoxicity, as a result of which tha functional-biochemical disorders in the liver show up to a lesser degree. During the combined use of antioxidants in indomethacin-induced lesions of the liver their hepatoprotective activity increases.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Indometacina/toxicidade , Animais , Antioxidantes/uso terapêutico , Doença Hepática Induzida por Substâncias e Drogas/etiologia , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Feminino , Peroxidação de Lipídeos/efeitos dos fármacos , Ratos , Fatores de Tempo
18.
Farmakol Toksikol ; 50(3): 97-9, 1987.
Artigo em Russo | MEDLINE | ID: mdl-3609289

RESUMO

Carbon tetrachloride administered together with ethanol was found in experiments on male albino rats to cause a severe liver damage. The use of unithiol, flakumin, tocopherol acetate, silymarin and silybor and also their combinations under these conditions not only decreases lipid hyperperoxidation and prevents depletion of the reduced glutathione pool but also retains a functional liver disturbance. Silybor, silymarin and tocopherol acetate in combination with flakumin proved to be the most efficient.


Assuntos
Antioxidantes/uso terapêutico , Intoxicação por Tetracloreto de Carbono/tratamento farmacológico , Doença Hepática Induzida por Substâncias e Drogas , Hepatopatias Alcoólicas/tratamento farmacológico , Animais , Intoxicação por Tetracloreto de Carbono/metabolismo , Avaliação Pré-Clínica de Medicamentos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Hepatopatias/tratamento farmacológico , Hepatopatias/metabolismo , Hepatopatias Alcoólicas/metabolismo , Masculino , Ratos
20.
Antibiot Med Biotekhnol ; 31(10): 781-4, 1986 Oct.
Artigo em Russo | MEDLINE | ID: mdl-3789688

RESUMO

It was shown in the experiments with albino rats that legalon and essentiale had a pronounced hepatoprotective effect in tetracycline affections of the liver. They retarded the increase in the activity of alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase in blood serum, prevented suppression of cholopoiesis by tetracycline and inhibited lipid peroxidation. The drugs may be used for prevention and treatment of tetracycline affections of the liver.


Assuntos
Antioxidantes/uso terapêutico , Flavonoides/uso terapêutico , Hepatopatias/tratamento farmacológico , Fosfatidilcolinas/uso terapêutico , Plantas Medicinais , Silimarina/uso terapêutico , Tetraciclina/toxicidade , Animais , Doença Hepática Induzida por Substâncias e Drogas , Avaliação Pré-Clínica de Medicamentos , Quimioterapia Combinada , Masculino , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA